Drug Hunter Revenue and Competitors

Drug Hunter™ is an essential resource for the community of R&D innovators turning molecules into medicines. Drug Hunter distills the science behind emerging drugs and technologies into an easy-to-read and simple-to-search reference. The company was founded in 2018 out of a scientist’s frustration with existing ways to learn about new drugs and the science of pharma. Now, thousands of R&D leaders from every major pharma and biotech company in the world choose to invest their time in Drug Hunter over crawling through the literature alone.\n\nOur products and subscription services including drughunter.com, the Drug Hunter Newsletter, Drug Hunter Events, and Drug Hunter Premium subscription make the science behind drug discovery easier to find, helping innovators keep up with best practices, find ideas, and identify partners with a fraction of the cost of traditional practices. Drug Hunter products and services are used by researchers at every major pharma and biotech in the world, leading universities like Harvard, and top VC and equity research firms.\n\nWe help drug hunters learn about technical products and services in partnership with relevant, technically-sophisticated sponsors. Our PhD team helps create relevant content for expert CROs, CDMOs, software, and equipment providers that are helpful to scientists.\n\nOur PhDs also consult for leading investment firms and market research divisions to understand critical issues in small molecule drug discovery. Reach out at drughunter.com/contact to find out how we can help you.